Fitzgerald Trait
Open Access
- 1 May 1975
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 55 (5), 1082-1089
- https://doi.org/10.1172/jci108009
Abstract
The prolonged partial thromboplastin time observed in the plasma of a 71-yr-old asymptomatic man was related to the deficiency of a hitherto unrecognized agent. The patient's plasma also exhibited impaired surface-mediated fibrinolysis and esterolytic activity and impaired generation of kinins and of the property enhancing vascular permeability designated PF/Dil. The patient's plasma contained normal amounts of all known clotting factors except Fletcher factor (a plasma prekallikrein) which was present at a concentration of 10-15% of pooled normal plasma. Fletcher trait plasma, however, contained normal amounts of the agent missing from the patient's plasma and corrected the defects in clotting, fibrinolysis, and vascular permeability. Fletcher trait plasma was less effective in correcting generation of kinins and esterolytic activity, presumably because of the patient's partial deficiency of prekallikrein. The site of action of the factor deficient in the patient's plasma appeared to be subsequent to the activation of Hageman factor and plasma prekallikrein. A fraction of normal plasma, devoid of other clotting factors, corrected the defect in clotting in the patient's plasma; a similar fraction of the patient's plasma did not correct this abnormality. No evidence yet exists pointing to the familial nature of the patient's defect. Tentatively, the patient's disorder may be referred to by his surname as Fitzgerald trait, and the agent apparently deficient in his plasma as Fitzgerald factor.This publication has 20 references indexed in Scilit:
- Fletcher Factor Activity in Plasmas of Various SpeciesExperimental Biology and Medicine, 1974
- Defective Esterase and Kinin-Forming Activity in Human Fletcher Trait PlasmaCirculation Research, 1974
- Defective Activation of Clotting, Fibrinolytic, and Permeability-Enhancing Systems in Human Fletcher Trait PlasmaCirculation Research, 1974
- Preparation, Characterization, and Activation of a Highly Purified Factor XI: Evidence that a Hitherto Unrecognized Plasma Activity Participates in the Interaction of Factors XI and XIIBritish Journal of Haematology, 1974
- Partial Purification of Plasma Thromboplastin Antecedent (Factor XI) and its Activation by TrypsinJournal of Clinical Investigation, 1973
- THE FIBRINOLYTIC PATHWAY OF HUMAN PLASMAThe Journal of Experimental Medicine, 1972
- The Kallikreinogen-Kallikrein Enzyme System of Human PlasmaAnnals of Internal Medicine, 1969
- Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactorsJournal of Clinical Investigation, 1969
- STUDIES ON KALLIKREIN: FAILURE OF SOME ANTI‐INFLAMMATORY DRUGS TO AFFECT RELEASE OF KININBritish Journal of Pharmacology and Chemotherapy, 1966
- Assay and Properties of Serum Inhibitor of C'1-EsteraseExperimental Biology and Medicine, 1959